Loading...
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
Amyloid-β (Aβ) and tau proteins currently represent the two most promising targets to treat Alzheimer's disease. The most extensively developed method to treat the pathologic forms of these proteins is through the administration of exogenous antibodies, or passive immunotherapy. In this review,...
Saved in:
| Published in: | Neurobiol Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
The Authors. Published by Elsevier Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7365083/ https://ncbi.nlm.nih.gov/pubmed/32682954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2020.105010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|